Danijela Miljanovic
- Hepatology top 10%
- Hepatitis C virus research 5
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 5
-
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 3
- Cytomegalovirus and herpesvirus research 3
-
- Viral-associated cancers and disorders 6
-
- Lymphoma Diagnosis and Treatment 6
-
- Systemic Lupus Erythematosus Research 3
Danijela Miljanovic
19 papers receiving 329 citations
Peers
Comparison fields: 5 of 58
- Hepatology 76
- Infectious Diseases 174
- Epidemiology 111
- Animal Science and Zoology 19
- Modeling and Simulation 8
Countries citing papers authored by Danijela Miljanovic
This map shows the geographic impact of Danijela Miljanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danijela Miljanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danijela Miljanovic more than expected).
Fields of papers citing papers by Danijela Miljanovic
This network shows the impact of papers produced by Danijela Miljanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danijela Miljanovic. The network helps show where Danijela Miljanovic may publish in the future.
Co-authorship network
The 15 scholars most cited alongside Danijela Miljanovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 18 | |
| 13 | 2023 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2021 | 34 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2021 | 120 | |
| 19 | 2020 | 1 | |
| 20 | 2019 | 64 |
About Danijela Miljanovic
Danijela Miljanovic is a scholar working on Hepatology, Pathology and Forensic Medicine and Infectious Diseases, having authored 20 papers that have together received 334 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Lymphoma Diagnosis and Treatment (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Hepatology (76 citations), Infectious Diseases (174 citations) and Epidemiology (111 citations). Danijela Miljanovic has collaborated with scholars based in Serbia and Montenegro. Frequent co-authors include Ivana Lazarević, Maja Ćupić, Ana Banko, Vera Pravica, Andja Ćirković, Ivica Jeremić, Ognjen Milićević, Džihan Abazović, Aleksandra Knežević and Biljana Jekić. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.